Avidity Partners Management LP Biogen Inc. Transaction History

Avidity Partners Management LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $14.8 Million - $16.8 Million	-58,600 Reduced 33.68%	115,400 $29.7 Million
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $12.4 Million - $14.4 Million	45,200 Added 35.09%	174,000 $49.6 Million
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $33 Million - $37.7 Million	128,800 New	128,800 $35.8 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $31 Million - $42.8 Million	159,434 Added 36.19%	600,000 $160 Million
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $14.2 Million - $16.9 Million	75,566 Added 20.7%	440,566 $89.8 Million
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $70.7 Million - $89.1 Million	365,000 New	365,000 $76.9 Million
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $52 Million - $67.9 Million	-183,900 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $47.6 Million - $76.3 Million	183,900 New	183,900 $63.7 Million
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $74.4 Million - $112 Million	-315,100 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$264.77 - $305.71 $83.4 Million - $96.3 Million	315,100 New	315,100 $89.4 Million
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $16 Million - $21.2 Million	-62,000 Closed	0 $0
Q1 2020 Jun 17, 2020	BUY	$268.85 - $341.04 $16.7 Million - $21.1 Million	62,000 New	62,000 $19.6 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

Stay updated on Avidity Partners Management LP with notifications on news.